Liminatus Pharma, Inc. (LIMN) Insider Trading

Name: Liminatus Pharma, Inc. (LIMN) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Jul 14, 2026): Valetudo Therapeutics LLC (10% Owner): Other (see footnotes) of 3,448,926 shares.

Get alerted when insiders trade LIMN

Email address

Loading company data...

Beta

Loading company details...

Beta